Antimicrobial Photosensitizers: Drug Discovery Under the Spotlight

Area of Science:

• Medicinal Chemistry
• Photochemistry
• Antimicrobial Research

Background:

• Photodynamic therapy (PDT), initially used for microorganisms, is now primarily a cancer treatment.
• Rising multi-antibiotic resistant pathogens necessitate novel antimicrobial approaches.
• PDT offers a versatile antimicrobial strategy to which microbes may not develop resistance.

Purpose of the Study:

• To review diverse chemical compounds investigated as antimicrobial photosensitizers.
• To highlight both established and rationally designed photosensitizers.
• To explore the potential of various chemical classes in antimicrobial PDT.

Main Methods:

• Survey of literature on chemical compounds tested for antimicrobial PDT.
• Categorization of photosensitizers based on chemical structure (tetrapyrroles, natural products, dyes, novel structures, photocatalysts).
• Analysis of structure-activity relationships, including charge and macrocycle effects on efficacy and spectral properties.

Main Results:

• Tetrapyrrole compounds with cationic charges show broad-spectrum efficacy and improved singlet oxygen generation.
• Structural modifications (porphyrins to bacteriochlorins) shift absorption to the near-infrared for better tissue penetration.
• Various natural products (curcumin, riboflavin, hypericin, psoralens) and synthetic dyes (phenothiazinium, xanthene, triarylmethane, indocyanine, BODIPY, squaraine, fullerene) are effective.
• Titanium dioxide photocatalysis also shows potential medical applications.

Conclusions:

• A wide array of chemical compounds, from natural products to novel synthetic structures, demonstrate potential as antimicrobial photosensitizers.
• Optimizing photosensitizer design, considering factors like charge and spectral properties, is crucial for enhanced efficacy.
• Antimicrobial PDT represents a promising therapeutic avenue against resistant infections, with ongoing research in photosensitizer development.